Effect of vernix caseosa on the penetration of chymotryptic enzyme: Potential role in epidermal barrier development

Pediatric Research

Volumn 62, Issue 1, 2007, Pages 49-53

  Tansirikongkol, Anyarporn ^a   Wickett, R Randall ^a   Visscher, Marty O ^a   Hoath, Steven B ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b Skin Sciences Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; CHYMOTRYPSIN A; DESITIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EPIDERMIS; FETUS (ANATOMY); HUMAN; HUMAN TISSUE; INFANT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; CHYMOTRYPSIN; EMOLLIENTS; ENZYME STABILITY; EPIDERMIS; FETUS; HUMANS; INFANT, NEWBORN; SKIN ABSORPTION; SKIN PHYSIOLOGY; VERNIX CASEOSA;

EID: 34250847039     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/PDR.0b013e318067b442     Document Type: Article

References (43)

1. Holbrook KA, Hoff MS 1984 Structure of the developing human-embryonic and fetal skin. Semin Dermatol 3:185-202
2. Hoeger PH, Schreiner V, Klaassen IA, Enzmann CC, Friedrichs K, Bleck O 2002 Epidermal barrier lipids in human vernix caseosa: corresponding ceramide pattern in vernix and fetal skin. Br J Dermatol 146:194-201
3. Agorastos T, Hollweg G, Grussendorf EI, Papaloucas A 1988 Features of vernix caseosa cells. Am J Perinatol 5:253-259
4. Pickens WL, Warner RR, Boissy YL, Boissy RE, Hoath SB 2000 Characterization of vernix caseosa: water content, morphology, and elemental analysis. J Invest Dermatol 115:875-881
5. Nicolaides N 1971 The structures of the branched fatty acids in the wax esters of vernix caseosa. Lipids 6:901-905
6. Downing DT, Strauss JS 1974 Synthesis and composition of surface lipids of human skin. J Invest Dermatol 62:228-244
7. Rissmann R, Groenink H, Weerheim A, Hoath S, Ponec M, Bouwstra J 2006 New insights into ultrastructure, lipid composition and organization of vernix caseosa. J Invest Dermatol 126:1823-1833
8. Oku H, Mimura K, Tokitsu Y, Onaga K, Iwasaki H, Chinen I 2000 Biased distribution of the branched-chain fatty acids in ceramides of vernix caseosa. Lipids 35:373-381
9. Youssef W, Wickett RR, Hoath S 2001 Surface free energy characterization of vernix caseosa. Potential role in waterproofing the newborn infant. Skin Res Technol 7:10-17
10. Akinbi HT, Narendran V, Pass AK, Markart P, Hoath S 2004 Host defense proteins in vernix caseosa and amniotic fluid. Am J Obstet Gynecol 191:2090-2096
11. Yoshio H, Tollin M, Gudmundsson GH, Lagercrantz H, Jornvall H, Marchini G, Agerberth B 2003 Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: implications for newborn innate defense. Pediatr Res 53:211-216
12. Visscher MO, Narendran V, Pickens W, Laruffa AA, Meinzen-Derr J, Allen K, Hoath S 2005 Vernix caseosa in neonatal adaptation. J Perinatol 25:440-446
13. Fartasch M, Ponec M 1994 Improved barrier structure formation in air-exposed human keratinocyte culture systems. J Invest Dermatol 102:366-374
14. Supp AP, Wickett RR, Swope VB, Harriger MD, Hoath SB, Boyce ST 1999 Incubation of cultured skin substitutes in reduced humidity promotes cornification in vitro and stable engraftment in athymic mice. Wound Repair Regen 7:226-237
15. Lentner C 1981 Geigy Scientific Tables, Unit of Measurement, Body Fluids, Composition of the Body, Nutrition. Ciba-Geigy Corporation, West Caldwell, pp 197-212
16. Gulbis B, Gervy C, Jauniaux E 1998 Amniotic fluid biochemistry in second-trimester trisomic pregnancies: relationships to fetal organ maturation and dysfunction. Early Hum Dev 52:211-219
17. Carrere J, Figarella C, Guy O, Thouvenot JP 1986 Human pancreatic chymotrypsinogen A: a non competitive enzyme immunoassay, and molecular forms in serum and amniotic fluid. Biochim Biophys Acta 883:46-53
18. Lozano P, Diego T, Iborra JL 1997 Dynamic Structure/function relationships in the a-chymotrypsin deactivation process by heat and pH. Eur J Biochem 248:80-85
19. Simon LM, Laszlo K, Kotorman M, Szajani B 2001 A comparative study of the conformational stabilities of trypsin and chymotrypsin. Acta Biol Szegediensis 45:43-49
20. Rutter N, Hull D 1979 Water loss from the skin of term and preterm babies. Arch Dis Child 54:858-868
21. Harpin VA, Rutter N 1983 Barrier properties of the newborn infant's skin. J Pediatr 102:419-425
22. Hardman MJ, Moore L, Ferguson MJ, Byrne C 1999 Barrier formation in the human fetus is patterned. J Invest Dermatol 113:1106-1113
23. Andersen PH, Bucher AP, Saeed L, Lee PC, Davis JA, Maibach HI 1994 Faecal enzymes: in vivo human skin irritation. Contact Dermatitis 30:152-158
24. Scott A 1958 A study of the action of chymotrypsin on the skin. J Invest Dermatol 30:201-205
25. Visscher MO, Hoath SB 2003 Diaper dermatitis. In: Maibach AH (ed) Handbook of Irritant Dermatitis. Springer-Verlag, Berlin, pp 37-51
26. Berg RW 1988 Etiology and pathophysiology of diaper dermatitis. Adv Dermatol 3:75-98
27. Tansirikongkol A 2006 Development of a synthetic vernix equivalent, and its water handling and barrier protective properties in comparison with vernix caseosa. Dissertation, University of Cincinnati, Cincinnati, OH
28. Hummel BW 1959 A modified spectrophotometric determination of chymotrypsin, trypsin and thrombin. Can J Physiol Pharmacol 37:1393-1399
29. Marchini G, Lindow S, Brismar H, Stabi B, Berggren V, Ulfgren A-K, Lonne-Rahm S, Agerberth B, Gudmundsson GH 2002 The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa. Br J Dermatol 147:1127-1134
30. Tollin M, Bergsson G, Kai-Larsen Y, Lengqvist J, Sjovall J, Griffiths W, Skuladottir GV, Haraldsson A, Jornvall H, Gudmundsson GH, Agerberth B 2005 Vernix caseosa as a multi-component defense system based on polypeptides, lipids and their interactions. Cell Mol Life Sci 62:2390-2399
31. Bautista MI, Wickett RR, Visscher MO, Pickens WL, Hoath SB 2000 Characterization of vernix caseosa as a natural biofilm: comparison to standard oil-based ointments. Pediatr Dermatol 17:253-260
32. Moraille R, Pickens W, Visscher MO, Hoath S 2005 A novel role for vernix caseosa as a skin cleanser. Biol Neonate 87:8-14
33. Hoath SB, Pickens W 2003 The biology of vernix. In: Hoath SB, Maibach H (eds) Neonatal Skin: Structure and Function. Marcel Dekker, New York, pp 193-210
34. Madison KC 2003 Barrier function of the skin: "La Raison d'Etre" of the epidermis. J Invest Dermatol 121:231-241
35. Horikoshi T, Igarashi S, Uchiwa H, Brysk H, Brysk MM 1999 Role of endogenous cathepsin D-like, and chymotrypsin-like proteolysis in human epidermis desquamation. Br J Dermatol 141:453-459
36. Johnson B, Horn T, Sander C, Kohler S, Smoller BR 2003 Expression of stratum corneum chymotryptic enzyme in ichthyoses and squamoproliferative processes. J Cutan Pathol 30:358-362
37. Hachem JP, Crumrine D, Fluhr J, Brown BE, Feingold KR, Elias PM 2003 pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 121:345-353
38. Skytt A, Stromqvist M, Egelrud T 1995 Primary substrate of recombinant human stratum corneum chymotryptic enzyme. Biochem Biophys Res Commun 211:586-589
39. Caplan RM 1966 The irritant role of feces in the genesis of perianal itch. Gastroenterology 50:19-23
40. Visscher M, Hoath SB, Conroy E, Wickett RR 2001 Effect of semipermeable membranes on skin barrier repair following tape stripping. Arch Dermatol Res 293:491-499
41. Edwards WH, Conner JM, Soll RF 2004 The effect of prophylactic ointment therapy on nosocomial sepsis rates and skin integrity in infants with birth weight of 501 to 1000 g. Pediatrics 113:1195-1203
42. Aly R, Shirley C, Cunico B, Maibach HI 1978 Effect of prolonged occlusion on the microbial flora, pH, carbon dioxide and transepidermal water loss on human skin. J Invest Dermatol 71:378-381
43. Proksch E, Holleran WM, Menon GK, Elias PM, Feingold KR 1993 Barrier function regulates epidermal lipid and DNA synthesis. Br J Dermatol 128:473-482